The discovery of an inner mucus layer normally impervious to bacteria has changed our way of understanding the interaction between commensal bacteria and the host epithelial cells. This inner colon mucus layer is rapidly renewed and converted into the outer mucus layer by host controlled endogenous proteolytic processing. The mucus characteristics esteem from the properties of the main protein component of these layers, the MUC2 mucin. This forms an enormously large net-like structure that builds the laminated inner mucus layer that largely acts as a size exclusion filter excluding bacteria. In the absence of MUC2 mucin, there is no inner mucus layer and bacteria reach the epithelial cell surface, penetrate the crypts and are also found inside epithelial cells, something that leads to severe inflammation. Other mouse models that spontaneously develop colitis due to different defects, like an absent ion channel (Nhe3) or immunological mediators (Tlr5, IL-10), all also have a defective inner colon mucus layer. Human patients with active ulcerative colitis have this layer penetrable to bacteria and beads the size of bacteria. Some of the ulcerative colitis patients in remission have a normal mucus layer whereas others have a penetrable inner mucus layer. Together, this suggests that the inner mucus layer and its integrity is important for the protection of the colon epithelium and inhibiting activation of the immune system as in ulcerative colitis.

Keywords:
Mucus, Mucin, Colon, Ulcerative colitis
1.
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism in the human intestine. Science 2005;307:1915-1920.
2.
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Weissenbach J, Ehrlich SD, Bork P: Enterotypes of the human gut microbiome. Nature 2011;473:174-180.
3.
Johansson MEV, Phillipson M, Petersson J, Holm L, Velcich A, Hansson GC: The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008;105:15064-15069.
4.
Johansson MEV, Sjovall H, Hansson GC: The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013;10:352-361.
5.
Johansson MEV, Holmen Larsson JM, Hansson GC: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 2011;108:4659-4665.
6.
Johansson MEV, Ambort D, Pelaseyed T, Schutte A, Gustafsson J, Ermund A, Subramani D, Holmen-Larsson J, Thomsson K, Bergstrom J, van der Post S, Rodriguez-Pineiro A, Sjovall H, Backstrom M, Hansson GC: Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 2011;68:3535-3641.
7.
Ambort D, Johansson MEV, Gustafsson JK, Nilsson H, Ermund A, Johansson BR, Kock P, Hebert H, Hansson GC: Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin. Proc Natl Acad Sci USA 2012;109:5645-5650.
8.
Godl K, Johansson MEV, Karlsson H, Morgelin M, Lidell ME, Olson FJ, Gum JR, Kim YS, Hansson GC: The N-termini of the MUC2 mucin form trimers that are held together within a trypsin-resistant core fragment. J Biol Chem 2002;277:47248-47256.
9.
Lidell ME, Johansson MEV, Mörgelin M, Asker N, Gum JR, Kim YS, Hansson GC: The recombinant C-terminus of the human MUC2 mucin forms dimers in CHO cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem J 2003;372:335-345.
10.
Gustafsson JK, Ermund A, Ambort D, Johansson MEV, Nilsson HE, Thorell K, Hebert H, Sjovall H, Hansson GC: Bicarbonate and functional CFTR channel is required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 2012;209:1263-1272.
11.
Johansson MEV: Fast renewal of the distal colonic mucus layers by the surface goblet cells as measured by in vivo labeling of mucin glycoproteins. PLoS One 2012;7:e41009.
12.
Johansson MEV, Gustafsson JK, Holmen-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, Hansson GC: Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and in patients with ulcerative colitis. Gut 2013, E-pub ahead of print.
13.
Gustafsson JK, Ermund A, Johansson MEV, Schutte A, Hansson GC, Sjovall H: An ex vivo method for studying mucus formation, properties and thickness in human colonic biopsies and mouse small and large intestinal explants. Am J Physiol Gastrointest Liver Physiol 2012;302:G430-G438.
14.
Velcich A, Yang WC, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002;295:1726-1729.
15.
Van der Sluis M, De Koning BAE, De Bruijn ACJM, Velcich A, Meijerink JPP, Van Goudoever JB, Buller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AWC: Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006;131:117-129.
16.
Isao O, Shigeru H, Masahiro Y, Toshifumi O, Yoshio I, Rintaro N: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
17.
Axelsson L, Landström E, Goldschmidt T, Grönberg A, Bylund-Fellenius A: Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4+-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 1996;45:181-191.
18.
Johansson MEV, Gustafsson JK, Sjoberg KE, Pettersson J, Holm L, Sjovall H, Hansson GC: Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010;5:e12238.
19.
Fu J, Wei B, Wen T, Johansson MEV, Xiaowei Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M, McDaniel M, Sferra TJ, Turner J, Chen H, Hansson GC, Braun J, Xia L: Loss of intestinal core 1-derived O-glycans causes spontaneous colitis. J Clin Invest 2011;121:1657-1666.
20.
Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, Neish AS, Uematsu S, Akira S, Williams IR, Gewirtz AT: Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007;117:3909-3921.
21.
Laubitz D, Larmonier CB, Bai A, Midura-Kiela MT, Lipko MA, Thurston RD, Kiela PR, Ghishan FK: Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis. Am J Physiol Gastrointest Liver Physiol 2008;295:G63-G77.
22.
Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-5231.
23.
Danese S, Fiocchi C: Ulcerative colitis. N Engl J Med 2011;365:1713-1725.
24.
Schirbel A, Fiocchi C: Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010;11:266-276.
25.
Carvalho FA, Koren O, Goodrich JK, Johansson MEV, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, Gonzlez A, Clemente JC, Cullender TC, Barnich N, Darfeuille-Michaud A, Vijay-Kumar M, Knight R, Ley RE, Gewirtz AT: Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012;12:139-152.
26.
Kuhn R, Löhler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
27.
Lidell ME, Moncada DM, Chadee K, Hansson GC: Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal part and dissolves the protective colonic mucus gel. Proc Nat Acad Sci USA 2006;103:9298-9393.
28.
Van der Post S, Subramani DB, Backstrom M, Johansson MEV, Vester-Christensen MB, Mandel U, Bennett EP, Clausen H, Dahlén G, Sroka A, Potempa J, Hansson GC: Site-specific O-glycosylation on the MUC2 mucin inhibits cleavage by the Porphyromonas gingivalis secreted cysteine protease (RgpB). J Biol Chem 2013;288:14636-14646.
29.
Subramani DB, Johansson MEV, Dahlén G, Hansson GC: Lactobacillus and Bifidobacterium species do not secrete proteases that can cleave the MUC2 mucin protein core which organizes the colon mucus layers. Benef Microbes 2010;1:343-350.
30.
Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S, Lochs H, Dorffel Y: Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007;56:343-350.
31.
Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B, Agace WW, Mowat AM: Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 2013;6:498-510.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.